graphic
News > Companies
Pharmacia antibiotic OK'd
April 18, 2000: 1:59 p.m. ET

New treatment Zyvox designed to battle 'superbugs' resistant to other drugs
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Federal regulators on Tuesday approved an antibiotic developed by Pharmacia Corp., the first in a new class of medicines designed to treat so-called "superbugs" commonly found in hospitals and nursing homes.
    The U.S. Food and Drug Administration cleared the drug, called Zyvox, to treat pneumonia and some types of infections that are resistant to other antibiotics.
    graphicThe drug, part of a new class of antibiotics called oxazolidinones, is designed to attack bacteria by blocking protein production at the early growth stages. In clinical studies, Zyvox had promising results in fighting off vancomycin-resistant enteroccus infections - infections resistant to vancomycin, an antibiotic commonly prescribed in hospitals.
    Potential side effects include headaches, nausea and diarrhea. The generic name for the antibiotic is Linezolid.
    Pharmacia (PHA: Research, Estimates) was formed earlier this month through the merger of Pharmacia & Upjohn and Monsanto Co. The company's shares slipped 1-5/16 to 52-13/16 in afternoon trading Tuesday. Back to top

  RELATED SITES

Pharmacia Corp.

Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic


© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.
Home | Contact Us | Advertise with Us | Corrections | Career Opportunities | Site Map
RSS | Email Delivery | Portfolio | Podcasts | Mobile | Widgets | User Preferences | Special Sections
| Magazine Customer Service | Download Fortune Lists | Reprints | Conferences | Business Leader Council